Onesource Specialty Pharma Limited has informed the Exchange about intimation of Amalgamation of two wholly owned subsidiaries of the Company
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited has informed the stock exchange about the proposed amalgamation of two of its wholly owned subsidiaries into the company. As both entities being merged are already fully owned by Onesource, there is no change in the shareholding pattern of the parent company. The merger is an internal consolidation move aimed at simplifying the corporate structure. The transaction will require approval from the National Company Law Tribunal (NCLT) and other regulatory authorities before it becomes effective.
This is an internal restructuring with no immediate impact on shareholders' ownership or the stock price. Over the longer term, it may lead to operational efficiencies and cost savings by reducing the number of legal entities, but investors should watch for NCLT approval timelines.